Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD ¿ a prospective interventional study
Adam Va¿ura; Ev¿en Machytka; Ond¿ej Urban; Jitka Machá¿ková; Lubomír Pavliska; Zden¿k Berka; Zden¿k ¿vagera; Marek Bu¿ga;
10.1016/j.aohep.2024.101765
Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
Chenyang Mu; Sijie Wang; Zenghan Wang; Jian Tan; Haozan Yin; Yuefan Wang; Zhihui Dai; Dongyang Ding; Fu Yang;
10.1016/j.aohep.2024.101774